Total: 2266

    Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023

    MMWR recomm. rep; RR-3 (1-39), 2023
    his report compiles and summarizes all published recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults aged ≥19 years in the United States. This report also includes updated and new clinical guidance for implementation from CDC. Bef...

    Intrapartum care

    This guideline covers the care of women and their babies during labour and immediately after birth. It focuses on women who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women to make informed choices about where to have their baby and about their care in labour. It al...

    ¿Cuál es el riesgo de las olas de calor y de altas temperaturas extremas en la salud?: Síntesis rápida de evidencia analítica

    Antecedentes y objetivo: El calor extremo es una amenaza para la salud y la vida, y en el último siglo, las altas temperaturas han aumentado considerablemente. Se espera que estos eventos sean más frecuentes e intensos debido al cambio climático. En este contexto, el Departamento de Gestión del Riesg...

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Nirsevimab, Season 1

    MMWR recomm. rep; 72 (34), 2023
    A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms of the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV)-associated lower respiratory tract infecti...

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Nirsevimab, Season 2

    MMWR recomm. rep; 72 (34), 2023
    A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) review of the evidence for benefits and harms for the long-acting monoclonal antibody nirsevimab, (Beyfortus, Sanofi and AstraZeneca) for prevention of respiratory syncytial virus (RSV))-associated lower respiratory tract infec...

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Safety of Influenza Vaccines for Persons with Egg Allergy

    MMWR recomm. rep; 72 (2), 2023
    Most of the influenza vaccines currently approved and available in the United States are produced by the propagation of influenza viruses in eggs (1-7). These vaccines therefore can contain small quantities of egg proteins. As of the 2022-23 influenza season, ACIP has recommended annual influenza vacci...

    A British Society for haematology guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies

    Br. j. haematol; 203 (4), 2023
    The objective of this guideline is to provide healthcare professionals with clear, up-to-date and practical guidance on the management of thrombotic thrombocytopenic purpura (TTP) and related thrombotic microangiopathies (TMAs), including complement-mediated haemolytic uraemic syndrome (CM HUS); these ar...

    Systemic therapy for melanoma: ASCO guideline update

    J. clin. oncol; 41 (30), 2023
    To provide guidance to clinicians regarding the use of systemic therapy for melanoma. American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review of the literature. The updated review identified 21 additional randomized trials. Neoadjuvant pembrolizumab was n...

    Is asynchronous telerehabilitation equal to synchronous telerehabilitation in COVID-19 survivors with classes 4–6?

    Introduction The first aim of this study was to compare synchronous and asynchronous telerehabilitation programs in COVID-19 survivors with classes 4–6 and determine the more appropriate telerehabilitation approach. Methods Thirty-six COVID-19 survivors with class 4–6 severity were randomly divided i...

    Effects of a cardiopulmonary telerehabilitation using functional exercises in individuals after COVID-19 hospital discharge: A randomized controlled trial

    Individuals with severe coronavirus disease 2019 (COVID-19) may present respiratory and motor complications, requiring rehabilitation programs (RP) for long periods. However, access to cardiopulmonary rehabilitation is poor. Cardiopulmonary telerehabilitation is an alternative for cardiopulmonary dysfunc...